Literature DB >> 19898182

The course of response to focal/grid photocoagulation for diabetic macular edema.

.   

Abstract

PURPOSE: The purpose of this study was to determine whether eyes with center-involved diabetic macular edema, treated with focal/grid photocoagulation, in which there is a reduction in central subfield thickness (CST) measured with optical coherence tomography after 16 weeks, will continue to improve if retreatment is deferred.
METHODS: This is a prospective, multicenter, observational, single-group focal/grid photocoagulation study of 122 eyes with center-involved diabetic macular edema (optical coherence tomography CST > or =250 microm). At the 16-week visit and continuing every 8 weeks, eyes were assessed for retreatment and additional laser treatment was deferred if the visual acuity letter score improved > or =5 letters or optical coherence tomography CST decreased > or =10% compared with the visit 16 weeks prior.
RESULTS: Of the 115 eyes that completed the 16-week visit, 54 (47%) had a decrease in CST by > or =10% compared with baseline. Of these, 26 (48%) had a CST > or =250 microm at 16 weeks and were evaluable at 32 weeks. Eleven (42%; 95% confidence interval, 23-63%) of the 26 eyes had a further decrease in CST > or =10% from 16 weeks to 32 weeks without further treatment.
CONCLUSION: Sixteen weeks after focal/grid laser for diabetic macular edema in eyes with a definite reduction, but not resolution, of central edema, 23% to 63% likely will continue to improve without additional treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19898182      PMCID: PMC2787248          DOI: 10.1097/IAE.0b013e3181bcef6b

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  14 in total

1.  Submacular fibrosis after photocoagulation for diabetic macular edema.

Authors:  D P Han; W F Mieler; T C Burton
Journal:  Am J Ophthalmol       Date:  1992-05-15       Impact factor: 5.258

2.  Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Early Treatment Diabetic Retinopathy Study Research Group.

Authors: 
Journal:  Ophthalmology       Date:  1987-07       Impact factor: 12.079

3.  Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME)

Authors:  L Akduman; R J Olk
Journal:  Ophthalmic Surg Lasers       Date:  1999 Nov-Dec

4.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd Paul Aiello; Roy W Beck; David M Brown; Donald S Fong; Neil M Bressler; Ronald P Danis; James L Kinyoun; Quan Dong Nguyen; Abdhish R Bhavsar; Justin Gottlieb; Dante J Pieramici; Michael E Rauser; Rajendra S Apte; Jennifer I Lim; Päivi H Miskala
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

5.  Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1985-12

6.  A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.

Authors: 
Journal:  Ophthalmology       Date:  2008-07-26       Impact factor: 12.079

7.  Subretinal fibrosis after laser photocoagulation for diabetic macular edema.

Authors:  D R Guyer; D J D'Amico; C W Smith
Journal:  Am J Ophthalmol       Date:  1992-06-15       Impact factor: 5.258

8.  Modified grid laser photocoagulation for diabetic macular edema. The effect on the central visual field.

Authors:  G G Striph; W M Hart; R J Olk
Journal:  Ophthalmology       Date:  1988-12       Impact factor: 12.079

9.  A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol.

Authors:  Roy W Beck; Pamela S Moke; Andrew H Turpin; Frederick L Ferris; John Paul SanGiovanni; Chris A Johnson; Eileen E Birch; Danielle L Chandler; Terry A Cox; R Clifford Blair; Raymond T Kraker
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

10.  Laser photocoagulation control of diabetic macular oedema without fluorescein angiography.

Authors:  A M Abu el Asrar; P H Morse
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

View more
  10 in total

1.  Three-dimensional imaging of the inner limiting membrane folding on the vitreomacular interface in diabetic macular edema.

Authors:  Sachi Abe; Teiko Yamamoto; Yoshiko Kashiwagi; Eriko Kirii; Sakiko Goto; Hidetoshi Yamashita
Journal:  Jpn J Ophthalmol       Date:  2013-10-11       Impact factor: 2.447

2.  Teleophthalmology image-based navigated retinal laser therapy for diabetic macular edema: a concept of retinal telephotocoagulation.

Authors:  Igor Kozak; John F Payne; Patrik Schatz; Eman Al-Kahtani; Moritz Winkler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-26       Impact factor: 3.117

Review 3.  Advances in the management of diabetic macular oedema based on evidence from the Diabetic Retinopathy Clinical Research Network.

Authors:  Lik Thai Lim; Seen Nee Chia; Elliott Yann Ah-Kee; Nejia Chew; Manish Gupta
Journal:  Singapore Med J       Date:  2015-05       Impact factor: 1.858

4.  Efficacy and safety of topical difluprednate in persistent diabetic macular edema.

Authors:  Savleen Kaur; Sonam Yangzes; Swati Singh; Nishant Sachdev
Journal:  Int Ophthalmol       Date:  2015-08-22       Impact factor: 2.031

5.  Ranibizumab for diabetic macular edema difficult to treat with focal/grid laser.

Authors:  Athanasios I Kotsolis; Elizabeth Tsianta; Maria Niskopoulou; Panagiotis Masaoutis; Stefanos Baltatzis; Ioannis D Ladas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-06-29       Impact factor: 3.117

6.  Five-year visual outcome following laser photocoagulation of diabetic macular oedema.

Authors:  S Jyothi; S Sivaprasad
Journal:  Eye (Lond)       Date:  2011-05-13       Impact factor: 3.775

7.  Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation.

Authors:  Joseph Googe; Alexander J Brucker; Neil M Bressler; Haijing Qin; Lloyd P Aiello; Andrew Antoszyk; Roy W Beck; Susan B Bressler; Frederick L Ferris; Adam R Glassman; Dennis Marcus; Cynthia R Stockdale
Journal:  Retina       Date:  2011-06       Impact factor: 4.256

8.  Characterization of microaneurysm closure after focal laser photocoagulation in diabetic macular edema.

Authors:  Su Na Lee; Jay Chhablani; Candy K Chan; Haiyan Wang; Giulio Barteselli; Sharif El-Emam; Maria L Gomez; Igor Kozak; Lingyun Cheng; William R Freeman
Journal:  Am J Ophthalmol       Date:  2013-02-06       Impact factor: 5.258

Review 9.  Recent advances in the management and understanding of diabetic retinopathy.

Authors:  Matthew Powers; Margaret Greven; Robert Kleinman; Quan Dong Nguyen; Diana Do
Journal:  F1000Res       Date:  2017-11-29

Review 10.  The Role of Focal Laser in the Anti-Vascular Endothelial Growth Factor Era.

Authors:  Jason N Crosson; Lauren Mason; John O Mason
Journal:  Ophthalmol Eye Dis       Date:  2017-11-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.